98%
921
2 minutes
20
This meta-analysis aimed to assess the impact of hyponatremia on prognosis in patients with traumatic brain injury (TBI), specifically regarding mortality and length of hospital stay. A systematic literature search was conducted in PubMed and Web of Science up to October 2024, using comprehensive search terms to cover all potential synonyms related to TBI and hyponatremia. Inclusion criteria required studies to be case-control in design, focus on TBI patients, and report on at least one outcome: mortality, length of stay, neurological scores (e.g., Glasgow Coma Scale), or functional recovery. Studies that were reviews, abstracts, or case reports were excluded, as were non-English publications. Data extraction and quality assessment were independently conducted by 2 reviewers, with a third reviewer resolving discrepancies. The Newcastle-Ottawa Scale (NOS) and Oxford Centre for Evidence-Based Medicine Levels were applied to assess study quality. Our findings indicate that although hyponatremia is common among TBI patients, it does not significantly increase mortality or extend hospital stay. This suggests that, although hyponatremia management is essential to prevent acute neurological complications, it may not critically impact overall patient outcomes in terms of survival or hospitalization duration. Future high-quality studies are needed to further clarify the role of hyponatremia in different TBI subtypes and its effect on long-term neurological recovery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SCS.0000000000011167 | DOI Listing |
J Vet Emerg Crit Care (San Antonio)
August 2025
University of Minnesota College of Veterinary Medicine, St. Paul, Minnesota, USA.
Objective: To compare survival between cats diagnosed with a nonketotic hyperosmolar hyperglycemic state (HHS) and cats diagnosed with diabetic ketoacidosis (DKA), and to determine whether clinical parameters, clinicopathologic data, and insulin type are associated with survival. Secondary objectives were to evaluate whether these parameters were associated with survival in cats undergoing a generalized hyperglycemic diabetic crisis.
Design: Retrospective evaluation of medical records of cats diagnosed with DKA and HHS between 2000 and 2020.
Neurosurg Rev
August 2025
Department of Neurosurgery, The Affiliated Jiangyin hospital of Nantong University, 214400, Jiangyin, China.
Dysnatremia and sodium variability are emerging prognostic markers in neurocritical care, yet their role in intracerebral hemorrhage (ICH) remains underexplored. This study investigates the independent and synergistic effects of serum sodium variability (coefficient of variation, CV) and absolute sodium levels on mortality in ICH patients. We conducted a retrospective cohort study using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Department of Internal Medicine, University of Health Sciences, Bursa Faculty of Medicine, Bursa City Training & Research Hospital, Bursa, Turkey.
Tolvaptan is an effective treatment for hyponatremia, but concerns about hepatotoxicity, mainly from high-dose, long-term use in autosomal dominant polycystic kidney disease, have limited its widespread application. This study aimed to assess the efficacy and hepatic safety of short-term, low-dose tolvaptan in hospitalized patients with severe hyponatremia, in comparison with 3% hypertonic saline. We retrospectively evaluated 236 hospitalized adults with severe hyponatremia (serum sodium < 125 mEq/L).
View Article and Find Full Text PDFAm J Cardiol
August 2025
Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; Department of Cardiology, Anzhen Hospital, Beijing, China. Electronic address:
This study describes clinical profiles of acute heart failure (AHF) patients from the Heart Failure Registry of Patient Outcomes (HERO) study and evaluates the prognostic impact of chronic obstructive pulmonary disease (COPD). HERO enrolled 5,620 hospitalized AHF patients (November 2017 to 2018); 4,428 were followed. Primary endpoint: composite all-cause death or heart failure (HF) readmission.
View Article and Find Full Text PDFFront Neurol
July 2025
Neurotherapeutics and Clinical Pharmacokinetics (Neuro-CPK) Laboratory, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada.
Pharmacotherapy variability is defined as the variability in drug response among and within individuals that is attributed to the inter and intra-individual differences in the action and disposition of drugs. Neurological and medical complications in neurocritical care contribute significantly to the overall disease prognosis. Pharmacological management plays a key role in managing many of those complications such as cerebral vasospasm, delayed cerebral ischemia, hyponatremia, infections, and seizures.
View Article and Find Full Text PDF